These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36301629)
1. Polypharmacy and multiple sclerosis: A population-based study. Chertcoff A; Ng HS; Zhu F; Zhao Y; Tremlett H Mult Scler; 2023 Jan; 29(1):107-118. PubMed ID: 36301629 [TBL] [Abstract][Full Text] [Related]
2. Antidepressant Use Among People Prescribed Opioids for Chronic Noncancer Pain. Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L Pain Med; 2019 Dec; 20(12):2450-2458. PubMed ID: 30861530 [TBL] [Abstract][Full Text] [Related]
3. Trends in central nervous system-active polypharmacy among people with multiple sclerosis. Naizer H; Wozny J; Krause TM; Huson E; Freeman L Mult Scler; 2024 Aug; 30(9):1139-1150. PubMed ID: 38751229 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of Central Nervous System-Active Polypharmacy Among Older Adults With Dementia in the US. Maust DT; Strominger J; Kim HM; Langa KM; Bynum JPW; Chang CH; Kales HC; Zivin K; Solway E; Marcus SC JAMA; 2021 Mar; 325(10):952-961. PubMed ID: 33687462 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH. Moore HN; Mao L; Oramasionwu CU AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
7. Prescribing of disease modifying agents in older adults with multiple sclerosis. Talwar A; Earla JR; Hutton GJ; Aparasu RR Mult Scler Relat Disord; 2022 Jan; 57():103308. PubMed ID: 35158421 [TBL] [Abstract][Full Text] [Related]
8. Drug use in persons with and without Alzheimer's disease aged 90 years or more. Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205 [TBL] [Abstract][Full Text] [Related]
9. The Association between Polypharmacy and Dementia: A Nested Case-Control Study Based on a 12-Year Longitudinal Cohort Database in South Korea. Park HY; Park JW; Song HJ; Sohn HS; Kwon JW PLoS One; 2017; 12(1):e0169463. PubMed ID: 28056068 [TBL] [Abstract][Full Text] [Related]
10. Epidemiological Insights on Medication Concurrency and Polypharmacy in People With Multiple Sclerosis in Greece. Bakirtzis C; Nikolaidis I; Boziki MK; Grigoriadou E; Karakasi MV; Moysiadis T; Kesidou E; Papazisis G; Grigoriadis N Int J MS Care; 2023; 25(4):140-144. PubMed ID: 37469336 [TBL] [Abstract][Full Text] [Related]
11. Polypharmacy in patients with multiple sclerosis: a gender-specific analysis. Frahm N; Hecker M; Zettl UK Biol Sex Differ; 2019 May; 10(1):27. PubMed ID: 31133051 [TBL] [Abstract][Full Text] [Related]
12. Polypharmacy Pattern in Iran: A Comprehensive Analysis of a Large Prescription Database. Ebrahimoghli R; Janati A; Gharaee H; Aghaei MH Iran J Pharm Res; 2022 Dec; 21(1):e131304. PubMed ID: 36915408 [TBL] [Abstract][Full Text] [Related]
13. Low socioeconomic status was associated with a higher mortality risk in multiple sclerosis. Calocer F; Ng HS; Zhu F; Zhao Y; Dejardin O; Leray E; Defer G; Evans C; Fisk JD; Marrie RA; Tremlett H Mult Scler; 2023 Mar; 29(3):466-470. PubMed ID: 36281835 [TBL] [Abstract][Full Text] [Related]
14. Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors. Frahm N; Hecker M; Zettl UK Sci Rep; 2019 Mar; 9(1):3743. PubMed ID: 30842515 [TBL] [Abstract][Full Text] [Related]
15. The pattern of medication use, and determinants of the prevalence of polypharmacy among patients with a recent history of depressive disorder: results from the pars cohort study. Ghaed-Sharaf M; Hariri S; Poustchi H; Nourollahi M; Khani S; Taherifard E; Mohammadi Z; Hadipour M; Sabaei R; Gandomkar A; Malekzadeh F; Vardanjani HM BMC Psychol; 2022 Jan; 10(1):12. PubMed ID: 35042543 [TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab and prescription medication use in the MS population. Chertcoff A; Ng HS; Zhu F; Zhao Y; Kingwell E; Tremlett H Mult Scler Relat Disord; 2020 Jul; 42():102086. PubMed ID: 32403069 [TBL] [Abstract][Full Text] [Related]
17. Polypharmacy among older adults with dementia compared with those without dementia in the United States. Growdon ME; Gan S; Yaffe K; Steinman MA J Am Geriatr Soc; 2021 Sep; 69(9):2464-2475. PubMed ID: 34101822 [TBL] [Abstract][Full Text] [Related]
18. Adherence to disease-modifying therapies for multiple sclerosis and subsequent hospitalizations. Evans C; Marrie RA; Zhu F; Leung S; Lu X; Kingwell E; Zhao Y; Tremlett H Pharmacoepidemiol Drug Saf; 2017 Jun; 26(6):702-711. PubMed ID: 28370875 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of prescription and non-prescription polypharmacy by frailty and sex among middle-aged and older Canadians. Harris DA; Guo Y; Nakhla N; Tadrous M; Hogan DB; Hennessy D; Langlois K; Garner R; Leslie S; Bronskill SE; Heckman G; Maxwell CJ Health Rep; 2022 Jun; 33(6):3-16. PubMed ID: 35876612 [TBL] [Abstract][Full Text] [Related]
20. Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population. Holtzman C; Armon C; Tedaldi E; Chmiel JS; Buchacz K; Wood K; Brooks JT; J Gen Intern Med; 2013 Oct; 28(10):1302-10. PubMed ID: 23605401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]